Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of CLS001 Gel in Papulopustular Rosacea
NCT02028286Phase 1Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Jan 2014
- Primary completion
- Mar 2014
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of omiganan in papulopustular rosacea, sponsored by Maruho Co., Ltd. Primary endpoint: Plasma concentrations of CLS001 at 24 days. Started Jan 2014; status: completed.
02
Drugs
omiganan
03
Conditions
papulopustular rosacea
Beyond the preview
Go deeper on NCT02028286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02028286.